Shine came to me and began with a fairly simple career question: if she is studying Drug Regulatory Affairs and Policy in Hong Kong, where can she begin doing proper Regulatory Affairs work?
The answer became less simple the longer we looked at it.
What we were looking at
Shine entered the programme with a clear direction. She wants to work in pharmaceutical Regulatory Affairs, ideally across European and Asian systems. Hong Kong is where she is studying, so it was reasonable to ask what kind of local experience the programme could help her obtain.
Her own market search had already produced an uncomfortable result. The large pharmaceutical companies she checked did not appear to maintain substantial Regulatory Affairs teams in Hong Kong. Those functions were more often located in places such as Shanghai, Singapore, or Europe. Hong Kong looked more like a commercial market than a regional regulatory centre.
The internship picture did not fully correct that impression. According to Shine’s account of the opportunities and private student discussions, the placement most clearly recognised as pharmaceutical Regulatory Affairs attracted strong interest from almost everyone. Some alternatives were labelled as Regulatory Affairs but appeared to contain mainly routine information checking. A government placement had an eligibility restriction. Medical-device and laboratory roles existed, but students did not necessarily regard them as substitutes for pharmaceutical Regulatory Affairs experience.
At a small-group meeting, Shine asked where graduates could gain experience while Hong Kong’s regulatory system was still developing. The advice she received was not to restrict herself to Regulatory Affairs, Pharmacovigilance, or Medical Affairs, because other jobs existed near those fields. She was also encouraged to think about what she could offer other people rather than what they could offer her.
The programme may open doors. What remained unclear was where those doors led.
This account comes from one student’s recollection and her view of a limited set of placements. It is not a complete employment survey. But it is enough to show the problem we were thinking about: a specialised programme is training students for a local professional ecosystem that may not yet be ready to absorb them.
The first hint: flexibility is doing two different jobs
Advice about flexibility can be useful. A graduate should not assume that one exact title is the only acceptable beginning.
But flexibility can also be used to cover a missing pathway.
If a programme trains students for Regulatory Affairs and then directs them toward finance, general consulting, laboratory work, or loosely related technical positions, those outcomes may prevent unemployment. They do not automatically demonstrate that the programme has built a route into Regulatory Affairs.
That distinction is easy to lose because employment statistics can sound reassuring. “Most graduates found something” answers one question. “Most graduates entered the profession they were trained for” answers another. A programme can perform well by the first measure and poorly by the second.
The hint behind the flexibility advice is therefore not necessarily that students chose too narrow a goal. It may be that the intended local market is too narrow to offer every student a credible entry point.
The second hint: competition cannot create the missing resource
Once suitable places are scarce, the conversation often turns toward making students more competitive. They should improve their CVs, network more actively, present their value more clearly, and become less selective.
All of those actions may help one person obtain a place. None of them creates another place.
If thirty capable students compete for three proper Regulatory Affairs positions, strengthening all thirty candidates changes the selection. It does not change the number three. The remaining twenty-seven students may still be talented, prepared, and unemployed in their intended profession.
This is where an institutional shortage can quietly become a personal accusation. A student who does not succeed may conclude that she was not proactive enough, not social enough, or not competitive enough. The market itself escapes examination.
Personal preparation matters, but it cannot replace employers, entry-level roles, supervision, or work that actually develops the promised professional skills.
The third hint: the students may be carrying the transition risk
Hong Kong is preparing to establish the Centre for Medical Products Regulation and move gradually toward primary evaluation of medical products. Under the current reliance-based route, approval from a recognised overseas regulator still performs an important part of the process. A fully developed primary-evaluation system would allow Hong Kong to make more original scientific decisions for itself.
That is a serious institutional ambition. It is also a long-term one. The official roadmap places the establishment of the centre in 2026 and the phased development of primary evaluation through 2030. An announced authority, a fully functioning regulator, and a surrounding labour market are not the same stage of development.
This creates a timing problem for current students. They are being trained in anticipation of a system that may become more important later, but they need internships and first jobs now. The eventual success of the regulator would not retroactively provide early-career experience to someone who graduated before the employment ecosystem was ready.
Being early is often described as an advantage. Sometimes it is. But early participants can also be the people who carry the uncertainty while institutions learn what they are becoming.
The programme may be contributing knowledge and future talent to Hong Kong’s regulatory development. That does not guarantee that today’s students will be the first beneficiaries of the system they are helping to justify.
What this means for Shine
Shine cannot control when the new regulator becomes fully capable or whether enough suitable junior positions appear before she graduates. She can look toward established Regulatory Affairs markets elsewhere while remaining open to a genuinely useful Hong Kong opportunity.
If the local resources are not ready, that is information about the market—not a judgment about her ability or commitment.
Where our thinking ended
Pharmaceutical Regulatory Affairs exists, but studying it in one place does not guarantee that the place already offers a functioning route into the profession.
Hong Kong may be building that route, but Shine does not need to wait beside the construction site. She can continue developing the direction she chose and look for work where the work already exists.